Who is sponsoring NCT03313700?

NCT03313700 is sponsored by Fujian Medical University.

What drugs are being tested in NCT03313700?

Interventions in NCT03313700: Robotic Distal Gastrectomy, Laparoscopic Distal Gastrectomy.

What condition does NCT03313700 study?

NCT03313700 studies Stomach Neoplasm, Robotic Surgery.

Is NCT03313700 still recruiting?

NCT03313700 is currently completed. Last updated 22 June 2023.

Last reviewed 2023-06-22 · How we verify

NCT03313700: RDG

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Outcomes of Robotic Versus Laparoscopic Distal Gastrectomy for Gastric Cancer

Completed NA Last updated 22 June 2023

What this trial tests

NA trial testing Robotic Distal Gastrectomy in Stomach Neoplasm in 300 participants. Completed in 13 January 2023.

Timeline

25 September 2017

Primary endpoint
13 January 2023

13 January 2023

Quick facts

Lead sponsor	Fujian Medical University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	300
Start date	25 September 2017
Primary completion	13 January 2023
Estimated completion	13 January 2023
Sites	1 location across China

Drugs / interventions tested

Robotic Distal Gastrectomy
Laparoscopic Distal Gastrectomy

Conditions studied

Stomach Neoplasm — all drugs for Stomach Neoplasm →
Robotic Surgery — all drugs for Robotic Surgery →

Sponsor

Fujian Medical University

Who can join

Adults 18 to 75, any sex, with Stomach Neoplasm or Robotic Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to explore the clinical outcomes of the robotic distal gastrectomy for patients with gastric adenocarcinoma（cT1-4a, N-/+, M0）.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Robotic versus laparoscopic distal gastrectomy for resectable gastric cancer: a randomized phase 2 trial.
Lu J, Xu BB, Zheng HL, Li P, et al · · 2024 · cited 23× · PMID 38821945 · DOI 10.1038/s41467-024-49013-6
Comparison of robotic versus laparoscopic versus open distal gastrectomy for locally advanced gastric cancer: a prospective trial-based economic evaluation.
Lu J, Wu D, Huang JB, Lin J, et al · · 2023 · cited 13× · PMID 37395806 · DOI 10.1007/s00464-023-10147-1
Current clinical trials on gastric cancer surgery in China.
Zhang S, Hu RH, Cui XM, Song C, et al · · 2024 · PMID 39554743 · DOI 10.4251/wjgo.v16.i11.4369

Verify or expand the search:

Other recruiting trials for Stomach Neoplasm

Currently open trials in the same condition.

NCT06732856 — A Phase Ib/II Trial of Neoadjuvant Zolbetuximab Plus Docetaxel, Oxaliplatin and S-1 Chemotherapy in Patients With Locall · Phase 1, PHASE2 · recruiting
NCT06028737 — Total Neoadjuvant FLOT Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer · Phase 2, PHASE3 · recruiting
NCT06923449 — Gastric Cancer' Textbook Oncological Outcome and Tumor Board Performance · recruiting
NCT05180864 — Omentum Preservation Versus Complete Omentectomy in Gastrectomy for Gastric Cancer · NA · recruiting
NCT05640609 — Capeox Regimen Combined With Sintilimab and Bevacizumab for Gastric Cancer · Phase 1, PHASE2 · recruiting

Other Fujian Medical University trials

Trials by the same sponsor.

NCT07314203 — Clinical Efficacy of Adebrelimab With or Without Apatinib Mesilate and SOX Neoadjuvant Therapy in Locally Advanced Gastr · Phase 3 · not yet recruiting
NCT07491263 — Clinical Study of Universal CD19 CAR-γδ T Cell Infusion in the Treatment of Relapsed/Refractory Acute B Lymphoblastic Le · Phase 1 · not yet recruiting
NCT07275034 — A Virtual Reality-Based Horticultural Planting Program for Elderly With Subthreshold Depression · NA · not yet recruiting
NCT07383909 — Remote Ischemic Preconditioning for Aute Type A Aortic Dissection Surgery · NA · recruiting
NCT07419932 — Response to Neoadjuvant Treatment in Locally Advanced Thyroid Cancer · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03313700 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Fujian Medical University
Last refreshed: 22 June 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03313700.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing